News
FDA accepts GSK's application to expand Arexvy vaccine use to at-risk adults aged 18–49, with a decision expected in the ...
Since AstraZeneca has quite a presence in the U.S. healthcare market and does much of its business in the country, it makes abundant sense to shift the main stock market listing and even the ...
(Alliance News) - The long-serving chief executive of AstraZeneca, Britain's most valuable public company, would like to move the stock market listing to the US, the Times reported on Tuesday. Shares ...
(Reuters) -AstraZeneca is considering moving its stock market listing from London, where it is the exchange's most valuable company, to the United States, the Times reported on Tuesday, citing ...
Land of opportunity Since AstraZeneca has quite a presence in the U.S. healthcare market and does much of its business in the country, it makes abundant sense to shift the main stock market ...
A newly configured federal vaccine panel's June 25 action is expected to improve options to protect infants from potentially deadly RSV.
Beyfortus, developed by the British-Swedish drugmaker AstraZeneca in partnership with the French pharmaceutical company Sanofi, was introduced in 2023 as game changing for infants since only one ...
The eight new ACIP members met for the first time June 25 after Kennedy fired all 17 original members of the committee June 9 ...
The Centers for Disease Control and Prevention's vaccine advisory committee is set to meet for the first time since Health Secretary Robert F. Kennedy Jr. fired the entire panel and named eight new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results